SVB Leerink analyst Whit Mayo initiates coverage on Privia Health Group (NASDAQ:PRVA) with a Outperform rating and announces Price Target of $35.
SVB Leerink Initiates Coverage On Privia Health Group with Outperform Rating, Announces Price Target of $35
SVB Leerink analyst Whit Mayo initiates coverage on Privia Health Group (NASDAQ:PRVA) with a Outperform rating and announces Price Target of $35.
Related Posts
Analyst Ratings For Bill.com Holdings
Analysts have provided the following ratings for Bill.com Holdings (NYSE:BILL) within the last quarter:
HC Wainwright & Co. Maintains Buy on Fate Therapeutics, Lowers Price Target to $115
HC Wainwright & Co. analyst Robert Burns maintains Fate Therapeutics (NASDAQ:FATE) with a Buy and lowers the price target from $122 to $115.
Didi to Hold Extraordinary General Meeting on May 23, 2022; Board Has Authorized Co to Organize Shareholders Meeting to Vote on Voluntary Delisting of the Company’s American Depositary Shares From NYSE
DiDi Global Inc. ("DiDi" or the "Company") (NYSE: DIDI) today announced that it will hold an extraordinary general meeting of shareholders (the "EGM") at No. 1 Block B, Shangdong Digital Valley, No. 8 Dongbeiwang West Road, Haidian District, Beijing, China on May 23, 2022 at 7:00 p.m., Beijing Time, or 7:00 a.m. Eastern Time.